A novel prognostic index for mortality in renal transplant recipients after hospitalization

Transplantation

Volumn 79, Issue 3, 2005, Pages 337-343

  Hernández, Domingo ^a   Rufino, Margarita ^a   Bartolomei, Sergio ^a   Lorenzo, Victor ^a   González Rinne, Ana ^a   Torres, Armando ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Mortality; Prognostic index; Renal transplantation

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; COMORBIDITY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT; RETROSPECTIVE STUDY; SURVIVAL RATE; UREMIA;

ADULT; AGED; CALCINOSIS; CARDIOVASCULAR DISEASES; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HOSPITALIZATION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROGNOSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 14544275194     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000151003.30089.31     Document Type: Article

References (30)

1. Feinstein A. The pre-therapeutic classification of comorbidity in chronic disease. J Chronic Dis 1970; 23: 455.
2. Schneeweiss S, Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 2000; 29: 891.
3. Wright LF. Survival in patients with end-stage renal disease. Am J Kidney Dis 1991; 17: 25.
4. Khan IH, Catto GRD, Edward N, et al. Influence of coexisting disease on survival on renal-replacement therapy. Lancet 1993; 341: 415.
5. Beddhu S, Zeidel ML, Saul M, et al. The effects of comorbid conditions on the outcomes of patients undergoing peritoneal dialysis. Am J Med 2002; 12: 696.
6. Van Manen JG, Korevaar JC, Dekker FW, et al. How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis 2002; 40: 82.
7. Miskulin DC, Meyer KB, Martin AA, et al. Comorbidity and its change predict survival in incident dialysis patients. Am J Kidney Dis 2002; 41: 149.
8. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(Suppl 3): S112.
9. Kasiske BL. Epidemiology of cardiovascular disease after renal transplantation. Transplantation 2001; 72(Suppl 6): S5.
10. Hernández D, Lacalzada J, Salido E, et al. Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism. Kidney Int 2000; 58: 889.
11. Rigatto C, Foley R, Jeffery R, et al. Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol 2003; 14: 462.
12. Kasiske BL, Guijarro C, Massy ZA, et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158.
13. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987; 40: 373.
14. Meier-Kriesche HU, Port FK, Ojo AO, et al. Effect of waiting time on renal transplant outcome. Kidney Int 2000; 58: 1311.
15. Ojo AO, Hanson JA, Wolfe RA, et al. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000; 57: 307.
16. Gill JS, Pereira BJG. Death in the first year after kidney transplantation: implications for patients on the transplant waiting list. Transplantation 2003; 75: 113.
17. Harrel FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361.
18. Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data. Med Care 2002; 40(Suppl): IV26.
19. Schneeweiss S, Seeger JD, Maclure M, et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001; 154: 854.
20. Herzog CA, Ma JZ, Collins AJ. Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. Am J Kidney Dis 2000; 36: 145.
21. Blacher J, Guerin AP, Pannier B, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938.
22. Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcome in the community. J Am Coll Cardiol 2003; 41: 47.
23. Fernandez-Fresnedo G, Rodrigo E, Escallada R, et al. Effect of early graft function on patient survival in renal transplantation. Transplant Proc 2003; 35: 1653.
24. Kasiske BL, Andany MA, Hernandez D, et al. Comparing methods for monitoring serum creatinine to predict late renal allograft failure. Am J Kidney Dis 2001; 38: 1065.
25. Wilson PWF, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837.
26. Uhlig K, Levey AS, Sarnak MJ. Traditional cardiac risk factors in individuals with chronic kidney disease. Semin Dial 2003; 16: 118.
27. Hemmelgarn BR, Manns BJ, Quan H, et al. Adapting the Charlson comorbidity index for use in patients with ESRD. Am J Kidney Dis 2003; 42: 125.
28. Breitenfeldt MK, Rasenack J, Berthold H, et al. Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clin Transplant 2002; 16: 130.
29. Morales JM, Campistol JM, Dominguez-Gil B. Hepatitis C virus infection and kidney transplantation. Semin Nephrol 2002; 22: 365.
30. Cosio FG, Falkenhain ME, Pesavento TE, et al. Patient survival after renal transplantation: II. The impact of smoking. Clin Transplant 1999; 13: 336.